Initiation of rivaroxaban in patients with nonvalvular atrial fibrillation at the primary care level: the Swiss Therapy in Atrial Fibrillation for the Regulation of Coagulation (STAR) Study. [electronic resource]
Producer: 20160610Description: 508-14 p. digitalISSN:- 1879-0828
- Aged
- Aged, 80 and over
- Atrial Fibrillation -- complications
- Factor Xa Inhibitors -- adverse effects
- Female
- Hemorrhage -- chemically induced
- Humans
- Male
- Middle Aged
- Primary Health Care
- Prospective Studies
- Risk Factors
- Rivaroxaban -- adverse effects
- Stroke -- drug therapy
- Switzerland
- Treatment Outcome
- Vitamin K -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.